UnitedHealth (UNH) Stock Analysis Amid DOJ Probe and Market Uncertainty

DOJ Probe and UnitedHealth's Response

• 📉 UnitedHealth (UNH) stock dropped nearly 11%, losing almost $100 billion in market cap, following reports of a DOJ investigation into potential criminal Medicare fraud.
• 📰 The Wall Street Journal reported the probe, but UNH stated they have not been notified by the Justice Department and stand by their Medicare Advantage business integrity.
• ⚠️ The stock is now trading at lows not seen since April 2020, down 55% from its November 11th all-time high.

Stock Performance and Sentiment Shift

• 🎢 UNH has faced a series of negative headlines, including the murder of its insurance unit CEO, a disappointing Q1 report, withdrawn guidance, and a CEO change.
• 💔 Sentiment shifted significantly around April 17th, moving from an "era of forgiveness" for its historic run to focusing on UNH-specific issues beyond general industry problems.
• 📉 Analysts from RBC, UBS, and Bernstein maintained constructive price targets and buy ratings, while UNH management called the WSJ report "deeply irresponsible."

Trading Opportunities and Future Outlook

• 🤔 Traders are divided on whether to trade UNH, with some seeing an opportunity in the significant price drop, while others advise caution.
• 📊 Some analysts believe the stock may be heading towards its March 2020 low of around $210, despite high trading volume.
• ⚠️ Concerns remain about medical utilization costs continuing to weigh on margins, potentially more than the current headlines.
• 💡 The company's significant reliance on Medicare Advantage (15% of membership, 30% of revenue) makes it vulnerable to these issues.
• ➡️ Some traders suggest looking at competitors like Elevance, which have stated they do not face the same issues.
• 📉 There's a view that more downside may be ahead due to recent guidance cuts, suggesting a cautious approach to UNH.
• 👨‍💼 The appointment of a new CEO, with extensive prior experience at the company, is seen positively, though it doesn't negate current challenges.